Taken together, these data suggest that in primary UM, TDO2 RNA expression is generally low (compared to other cancers), but the increased TDO2 RNA expression is associated with the poor prognosis markers, BAP1 mutations, and M3. The gene discussed is TDO2; the disease is cancer.